Stay updated on ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry v3.7.0, and the previously listed revision v3.6.6 has been removed.
    Difference
    0.1%
    Check dated 2026-09-15T22:26:10.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' appears in the study record history. This replaces the previous 'Revision: v3.6.5' and indicates an additional update to the record.
    Difference
    0.1%
    Check dated 2026-09-01T19:46:18.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the history, replacing v3.6.4, reflecting a software/UI update to the page.
    Difference
    0.1%
    Check dated 2026-08-11T14:59:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.4), indicating a page version update. This change affects only the page's metadata and does not modify the study data, conditions, or listings.
    Difference
    0.1%
    Check dated 2026-07-28T04:59:10.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous entry v3.6.2 was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-06T18:19:09.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the study record history, and the previous revision v3.6.0 was removed.
    Difference
    0.1%
    Check dated 2026-06-29T15:51:31.000Z thumbnail image

Stay in the know with updates to ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.